These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 11588183)

  • 1. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease.
    Akerud P; Canals JM; Snyder EY; Arenas E
    J Neurosci; 2001 Oct; 21(20):8108-18. PubMed ID: 11588183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
    Cunningham LA; Su C
    Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.
    Bensadoun JC; Déglon N; Tseng JL; Ridet JL; Zurn AD; Aebischer P
    Exp Neurol; 2000 Jul; 164(1):15-24. PubMed ID: 10877911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ.
    Espejo EF; Gonzalez-Albo MC; Moraes JP; El Banoua F; Flores JA; Caraballo I
    J Neurosci; 2001 Dec; 21(24):9888-95. PubMed ID: 11739596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
    Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
    Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures.
    Meyer M; Matarredona ER; Seiler RW; Zimmer J; Widmer HR
    Neuroscience; 2001; 108(2):273-84. PubMed ID: 11734360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
    Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
    J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
    Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
    Apostolides C; Sanford E; Hong M; Mendez I
    Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDNF-pretreatment enhances the survival of neural stem cells following transplantation in a rat model of Parkinson's disease.
    Wang F; Kameda M; Yasuhara T; Tajiri N; Kikuchi Y; Liang HB; Tayra JT; Shinko A; Wakamori T; Agari T; Date I
    Neurosci Res; 2011 Sep; 71(1):92-8. PubMed ID: 21699926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
    Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
    Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons.
    Akerud P; Alberch J; Eketjäll S; Wagner J; Arenas E
    J Neurochem; 1999 Jul; 73(1):70-8. PubMed ID: 10386956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease.
    Akerud P; Holm PC; Castelo-Branco G; Sousa K; Rodriguez FJ; Arenas E
    Mol Cell Neurosci; 2002 Oct; 21(2):205-22. PubMed ID: 12401443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.
    Rosenblad C; Martinez-Serrano A; Björklund A
    Neuroscience; 1996 Dec; 75(4):979-85. PubMed ID: 8938733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
    Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL
    BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
    Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
    Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.
    Wang Y; Tien LT; Lapchak PA; Hoffer BJ
    Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
    Aoi M; Date I; Tomita S; Ohmoto T
    Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.